Trial Profile

Simultaneous Study of Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention Strategies.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil
Indications Early breast cancer
Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
Acronyms SUCCESS-C

Most Recent Events

04 Jun 2013 Results reporting data on prevalence and quantity of circulating tumour cells presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
19 Apr 2013 Biomarkers information updated
18 Apr 2013 Planned End Date changed from 1 Feb 2014 to 1 Sep 2016 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com